India emerges as Global Leader in issuing Compliance Certificates under Nagoya Protocol

1. At a Glance

India tops the world in issuing Internationally Recognised Certificates of Compliance (IRCCs) under the Nagoya Protocol on Access and Benefit-Sharing (ABS), contributing ~56% of global IRCCs [S1][S2].
Relevant for GS-III (biodiversity, environment) and GS-II (international treaties); intersects with CBD, Biological Diversity Act, 2002, and National Biodiversity Authority (NBA) [S1][S2].

31 March 2026: Ministry of Environment, Forest and Climate Change (MoEFCC) announced India had issued 3,561 of 6,311 global IRCCs on the ABS Clearing-House [S1].
Follows India's submission of its First National Report on Nagoya Protocol implementation to the CBD Secretariat on 27 February 2026 [S2].

1992: Convention on Biological Diversity (CBD) adopted at Rio Earth Summit; three objectives — conservation, sustainable use, and fair & equitable sharing of benefits from genetic resources [S2].
2002: India enacts the Biological Diversity Act to give effect to CBD obligations [S2].
29 Oct 2010: Nagoya Protocol adopted at COP-10 (Nagoya, Japan), a supplementary agreement to CBD on ABS [S3].
2012: India signs Nagoya Protocol [S3].
2014: India ratifies the Protocol; Protocol enters into force globally on 12 October 2014 [S3].
2024: Biological Diversity Rules, 2024 notified; 2025: ABS Regulations, 2025 notified [S2].

Parent treaty: Convention on Biological Diversity (CBD), 1992 [S2].
Protocol full name: Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization [S2].
Implementing ministry (India): Ministry of Environment, Forest and Climate Change (MoEFCC) [S1].
Nodal agency: National Biodiversity Authority (NBA), Chennai — statutory body under BD Act 2002 [S2].
Statutory base: Biological Diversity Act, 2002; Section 3(2) (foreigners/NRIs/foreign entities — NBA approval) and Section 7 (Indian entities — SBB intimation) [S2].
Global platform: ABS Clearing-House — promotes transparency; 142 countries registered, only 34 have issued IRCCs [S1].
India's tally: 3,561 IRCCs (~56% of 6,311 global) [S1].
Rankings: India > France (964) > Spain (320) > Argentina (257) > Panama (156) > Kenya (144) [S1].
ABS approvals (2017–2025): 12,830 total — 5,913 by NBA (Sec 3(2)) + 6,917 by State Biodiversity Boards/UTBCs (Sec 7) [S2].
Monetary benefits: ₹216.31 crore (~USD 28.04 million) mobilised; ₹139.69 crore disbursed to benefit claimers including Biodiversity Management Committees (BMCs) [S2].

Environmental: Operationalises the third CBD pillar — benefit-sharing — discouraging biopiracy of genetic resources and associated traditional knowledge [S2][S3].
Legal / Constitutional: BD Act 2002 traces to Article 48A and 51A(g); three-tier institutional structure — NBA (central), SBBs (state), BMCs (local) [S2].
Economic: Monetary flows of ₹216 crore channelled to local communities; commercialisation of bioresources for pharma, cosmetics, agri-biotech [S2].
Ethical / Governance: Reinforces Prior Informed Consent (PIC) and Mutually Agreed Terms (MAT) with resource-providing communities; transparency via ABS Clearing-House [S1][S2].
Geopolitical: Positions India as a leader in the Global South on biodiversity diplomacy, ahead of mega-diverse peers like Brazil; complements India's stance at CBD COPs on Digital Sequence Information (DSI) [S1].

2024: Biological Diversity Rules, 2024 notified, operationalising amended BD Act [S2].
2025: ABS Regulations, 2025 notified — revised framework for access fees and benefit-sharing slabs [S2].
27 Feb 2026: India submits First National Report on Nagoya Protocol to CBD Secretariat [S2].
31 Mar 2026: PIB release on India's global IRCC leadership [S1].

Nagoya Protocol adopted at CBD COP-10, 2010, in Nagoya, Japan [S3].
Nagoya Protocol entered into force on 12 October 2014 [S3].
India ratified Nagoya Protocol in 2014 [S3].
Nodal Indian agency: National Biodiversity Authority (NBA), headquartered in Chennai [S2].
Statutory backing in India: Biological Diversity Act, 2002 (amended; Rules 2024, ABS Regulations 2025) [S2].
ABS three-tier structure: NBA – SBB – BMC [S2].
Section 3(2) of BD Act — applies to foreign nationals/entities needing NBA approval [S2].
India issued 3,561 IRCCs, ~56% of 6,311 global total [S1].
Only 34 of 142 ABS Clearing-House countries have issued any IRCC [S1].
Top 5 after India: France, Spain, Argentina, Panama, Kenya [S1].
Monetary benefit mobilised 2017–25: ₹216.31 crore; disbursed: ₹139.69 crore [S2].
Protocol is supplementary to CBD (1992) — not a standalone treaty [S2].
Key ABS principles: PIC (Prior Informed Consent) and MAT (Mutually Agreed Terms) [S2].

GS-III: Conservation, environmental pollution; biodiversity governance.
GS-II: Important International Institutions; bilateral/multilateral agreements.
Question stems:
"Discuss how India's Biological Diversity Act, 2002, operationalises the Nagoya Protocol. Examine recent reforms (Rules 2024, ABS Regulations 2025)."
"India accounts for over half of global IRCCs under the Nagoya Protocol. What does this signify for biodiversity governance in the Global South?"
"Examine the role of the three-tier NBA–SBB–BMC structure in preventing biopiracy and securing benefit-sharing for local communities."

Convention on Biological Diversity (CBD), 1992 — parent treaty.
Cartagena Protocol on Biosafety (2000) — sister CBD protocol on LMOs.
Kunming-Montreal Global Biodiversity Framework (2022) — 30x30 targets.
Biological Diversity (Amendment) Act, 2023 — eased compliance for AYUSH/codified traditional medicine.
Digital Sequence Information (DSI) — emerging ABS issue at CBD COPs.
TKDL (Traditional Knowledge Digital Library) — defensive protection against biopiracy.
PBR (People's Biodiversity Registers) — maintained by BMCs.
Biopiracy cases: Neem, Turmeric, Basmati — historical precedents.

Nagoya Protocol is under CBD, NOT UNFCCC or UNCCD.
NBA is under MoEFCC, headquartered in Chennai (not Delhi).
Nagoya Protocol adopted 2010, entered into force 2014 — distinct dates.
BD Act is 2002; Rules notified in 2024; ABS Regulations in 2025 — don't conflate.
Cartagena Protocol (biosafety/LMOs) ≠ Nagoya Protocol (ABS) ≠ Nagoya–Kuala Lumpur Supplementary Protocol (liability).
IRCCs are issued by national competent authorities and published on the ABS Clearing-House, not by the CBD Secretariat itself.

[S1] India emerges as Global Leader in issuing Compliance Certificates under Nagoya Protocol — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2247141 — (tier: 1)
[S2] India Submits 1st National Report on Implementation of Nagoya Protocol on ABS to CBD — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2240577 — (tier: 1)
[S3] India facilitates entry into force of Nagoya Protocol on Access and Benefit Sharing — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=106871 — (tier: 1)